Abstract
Introduction
Nausea, retching and vomiting are common among the post operative complications following surgery & anaesthesia 1 . Although often regarded by medical and nursing staffs as only a minor complication of anaesthesia and surgery, these are frequently the cause of great distress to patients and it is often the worst memory of their hospital stay. 2 In the past, the incidence of post-operative nausea and vomiting was reported to be as high as 60% (range 14-82%) following operation under general anaesthesia. 3 The aetiology of nausea and vomitnig after surgery is multifactorial in origin. Age, menstrual cycle, type of surgery and anaesthetic procedure may influence PONV. 4 Many drugs have been tried to prevent or alleviate this problem. The antiemetics that are currently being widely used for treatment in our country are prochlorperazine, metoclopramide and promethazine. But these drugs have varying effectiveness and their use is limited because of delayed recovery, sedation and sometimes distressing side effect of extrapyramidal symptoms. 5, 6, 7 . The introduction of 5HT 3 receptor antagonist in 1990s was heralded as a major advance in the treatment of PONV because of the
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. absence of adverse effect that were observed with commonly used traditional antiemetics. 8, 9 The commonly used drug ondansetron 8 4 mg I/V single dose is the effective dose to prevent PONV. 10 Recently introduced another 5HT 3 receptor antagonist granisetron has more potent and longer acting activity against cisplatin induced emesis than ondansetron. 11 Recent study demonstrated that granisetron reduces the incidence and severity of vomiting following strabismus repair and tonsillectomy. 12 
Methods
After obtaining approval of the institutional ethical committee of SSMC and Mitford Hospital 60 (sixty) women of ASA class I or II, scheduled for elective total abdominal hysterectomy were enrolled in the study. Written informed consent was taken from the patients. They were randomly divided into two groups of 30patients each. Group-'O': 30 patients received, ondansetron 8mg (4ml) intravenously (I/ V) single dose just before peritoneal closure. Group-'G': 30 patients received, granisetron 2mg I/V single dose just before peritoneal closure. In the preoperative period, the procedure was explained to the patients and informed consent was obtained from each patient. In the preoperative period patients were also enquired about motion sickness, history of previous anaesthesia and postoperative emesis. On arrival of the patients in the operation theatre I/V line was inserted and pulse rate, blood pressure and respiratory rate were recorded. Patients were preoxyginated for three minutes and induction was done with fentanyl 1ìg/kg, thiopentone 5mg/kg, tracheal intubation was facilitated by suxamethonium 1.5mg/kg and general anaesthesia was maintained by halothane 0.5%, N 2 O 60% with O 2 40%. nondepolarizing muscle relaxant vecuronium 0.1 mg/kg was given. Intraoperative proper hydration was maintained with Hartman's solution. Just before peritoneal closure ondansetron 8mg in Group 'O' patient and granisetron 2mg Group 'G' patient I/V was given. At end of operation patient was reversed accordingly with neostigmine 0.05mg/ kg plus atropine 0.02 mg/kg and recovery was smooth and uneventful. Intraoperative and postoperative monitoring were NIBP, ECG, SpO 2 .
In the recovery room post operative analgesia was provided with diclofenac suppository (50mg) stat and ketorolac tromethamine 30mg intramuscularly 8 hourly on complaining pain and repeated in all patients when necessary. For presence of nausea and vomiting, patients were interviewed at one hourly over the first 3 hours then at 3 hourly up to 12 hours postoperative period. The 12 hours study period was begun upon entry to the recovery room. The number and time of emetic episodes and the number & time of rescue antiemetic treatment was recorded. The rescues protocol constituted of granisetron/ ondansetron injected once. Patients were carefully observed for any adverse effect like sedation, drowsiness, flushing of any extrapyramidal symptoms.
Results

Demographic data of patients shown in table-I.
No clinically significant difference in heart rate in intraoperative and postoperative period were seen between the groups in time interval (Fig-1) Statistically no significant difference was also observed in mean blood pressure during operation and postoperatively between the groups (Fig-2) Statistically no significant difference was also observed in SpO 2 during operation and postoperatively between the groups (Fig-3 
Discussion
Nausea and vomiting are common and frequent complications following surgery and anaesthesia. Most of the incidence of nausea and vomiting occur during the first two hours of recovery from anaesthesia. The etiology of postoperative nausea and vomiting is multi-factorial. Many factor associated with anaesthesia and surgery may contribute to nausea and vomiting. In the present study concern factors are type of anaesthesia, female patient and gynecological surgery. Incidence of nausea and vomiting is two to three times more in female due to changing endocrine environment which sensitize the brain stem emetic mechanism. During elective gynaecological surgery, general anaesthesia as well as some traction of vagal innervated gut may play role in triggering emesis.
The reported overall incidence of nausea and vomiting after gynecological surgery is 75%. 13 The antiemetics are now mainstay of therapy to prevent PONV. The antiemetics that are now currently being widely used for treatment in our country are prochlorperazine, metoclopramide and promethazine and many study have done with these drugs. But these drugs have varying effectiveness and there use is limited because of delayed recovery, sedation and sometimes distressing side effect of extrapyramidal symptoms. 5, 6, 7 Malins et al. have also studied the efficacy of ondansetron compared with metoclopramide. 14 Alon & Himmelseher studied the efficacy of a single intravenous dose of ondansetron 8mg, droperidol 1.25 mg and metroclopramide 10 mg given preoperatively to gynaecologicla patients undergoing dilatation and curettage. 15 Granisetron is a newer drug and limited studies have done with this drug in our country. So we have chosen ondansetron and granisetron for prevention of PONV in elective gynaecological surgery to compare these drugs about their efficacy and side effects during operations and 12 hours post operative period.
In the present study incidence of nausea and vomiting in group-O (those received Ondansetron 16 with his co-worker shows that prophylactic antiemetic treatment with ondansetron resulted in a lower incidence of PONV than with metochlopramide and placebo in a randomized double blind comparative study on laparoscopic cholecystectomy. In another study Dipasri Bhattacharya 17 et al shows that granisetron is much better than ondansetron for prevention of PONV following day case gynecological laparoscopy in a randomized double blind technique. In another study D. Bridges 18 , BS (Pharm) showed that low dose granisetron was equally effective as ondansetron, dolasetron with no toxicity in female patients at high risk for PONV.
In our study most of the incidence of PONV occur with first two hours after surgery in two groups but in rest of the period no nausea and vomiting occur which is similar with the study of Dr. Bridges 18 . It has some dissimilarities with the study of Naguib 16 and Dipasri Bhattacharya 17 . The aggravating factor for PONV in general anaesthesia are anaesthetics agents, distention by gas, per and postoperative use of narcotics. But in our study the possible aggravating factor are female patient general anaesthesia, vagal irritation.
Regarding hemodynamic changes SpO 2 , during operation and 12 hours post operative period no clinically significant changes occur. No other adverse effect like headache, constipation and flushing during operation and 12 hours postoperative period were observed in this study.
Pain as well as commonly used analgesic pethidine may cause nausea and vomiting. For this reason postoperative control of pain we used ketorolac tromethamine and diclofenac as required instead of pethidine. The study confirmed the previous study regarding the safety of the patient as side effects were mild.
Conclusion
Both the ondansetron and granisetron have similar antiemetic efficacy.
